Contact
searchSearch
HMP Global

Thrombectomy: Features

Interview
STRIDE Study: When ALI Is Treated With Mechanical Aspiration Thrombectomy, Race, Not Sex, Is Associated With Adverse Outcomes
03/05/2025
Alex Powell, MD
VDM spoke with Dr Powell to discuss the surprising results from the STRIDE study, which looked at the use of the Indigo Aspiration System (Penumbra) for acute limb ischemia.
VDM spoke with Dr Powell to discuss the surprising results from the STRIDE study, which looked at the use of the Indigo Aspiration System (Penumbra) for acute limb ischemia.
VDM spoke with Dr Powell to...
03/05/2025
Vascular Disease Management
Interview
STRIKE-PE: Interim Analysis of the First 300 Patients Using Lightning Flash
03/05/2025
Brian J. Schiro, MD
VDM spoke with Dr Schiro about STRIKE-PE, a study that evaluated the efficacy and long-term safety outcomes of treating PE with Lightning Flash (Penumbra).
VDM spoke with Dr Schiro about STRIKE-PE, a study that evaluated the efficacy and long-term safety outcomes of treating PE with Lightning Flash (Penumbra).
VDM spoke with Dr Schiro about...
03/05/2025
Vascular Disease Management
Stroke Treatment
Philips, World Bank, and Ukraine Ministry of Health Announce Successful Deployment of Nationwide Acute Stroke Care Upgrade, Helping Thousands of Patients
02/10/2025
Groundbreaking program that provides technology and training is reducing the impact of stroke, one of the leading causes of death and disability, by establishing an advanced nationwide acute stroke treatment network Amsterdam, the...
Groundbreaking program that provides technology and training is reducing the impact of stroke, one of the leading causes of death and disability, by establishing an advanced nationwide acute stroke treatment network Amsterdam, the...
Groundbreaking program that...
02/10/2025
Vascular Disease Management
Thrombectomy
Inquis Medical Completes Enrollment in U.S. Pivotal IDE Trial of the Aventus Thrombectomy System Designed to Treat Patients With Pulmonary Embolism
01/13/2025
MENLO PARK, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Inquis Medical, a leading innovator in venous thromboembolic disease treatment, today announced completion of patient enrollment in its AVENTUS Clinical Trial, a pivotal Investigational...
MENLO PARK, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Inquis Medical, a leading innovator in venous thromboembolic disease treatment, today announced completion of patient enrollment in its AVENTUS Clinical Trial, a pivotal Investigational...
MENLO PARK, Calif., Jan. 13,...
01/13/2025
Vascular Disease Management
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Dr Marc Salhanick
Sponsored Interview
Latest Computer Assisted Vacuum Thrombectomy Designed to Enhance Efficiency and Blood Loss Reduction
09/30/2024
VDM spoke with vascular surgeon Marc Salhanick, MD, from Complex Vascular in Dallas, Texas, about treating PE with the Penumbra Lightning Flash® 2.0 computer assisted vacuum thrombectomy (CAVT™) system and how his practice has evolved.
VDM spoke with vascular surgeon Marc Salhanick, MD, from Complex Vascular in Dallas, Texas, about treating PE with the Penumbra Lightning Flash® 2.0 computer assisted vacuum thrombectomy (CAVT™) system and how his practice has evolved.
VDM spoke with vascular surgeon...
09/30/2024
Vascular Disease Management
Dr Barkat
Sponsored Interview
Treating Pulmonary Embolism With Penumbra Lightning Flash 2.0
08/12/2024
VDM spoke with vascular surgeon Adel Barkat, MD, from the Oklahoma Heart Institute in Tulsa, Oklahoma, about treating PE with the Penumbra Lightning Flash 2.0 computer assisted vacuum thrombectomy (CAVT) system and how it has changed his...
VDM spoke with vascular surgeon Adel Barkat, MD, from the Oklahoma Heart Institute in Tulsa, Oklahoma, about treating PE with the Penumbra Lightning Flash 2.0 computer assisted vacuum thrombectomy (CAVT) system and how it has changed his...
VDM spoke with vascular surgeon...
08/12/2024
Vascular Disease Management
Interview
New Tools for Eliminating Venous Obstruction and Valvular Reflux
06/27/2024
At the 2024 SIR Meeting, interventional radiologist Kush Desai, MD, presented several sessions, including one on this topic. VDM spoke with Dr. Desai about his presentation and the latest thrombectomy devices.
At the 2024 SIR Meeting, interventional radiologist Kush Desai, MD, presented several sessions, including one on this topic. VDM spoke with Dr. Desai about his presentation and the latest thrombectomy devices.
At the 2024 SIR Meeting,...
06/27/2024
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

VentiV Clinical Images
Thrombectomy
FDA Clears New Mechanical Thrombectomy System
03/31/2025
VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform.
VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform.
VentiV Scientific announced the...
03/31/2025
Cath Lab Digest
Restenosis
Real-world Data Shows Cook’s Zilver PTX Leads to Lower Rates of In-stent Occlusion Than Boston Scientific’s Eluvia
03/27/2025
Bloomington, Ind. — Cook Medical’s Zilver PTX drug-eluting stent (DES) has lower rates of in-stent occlusions among patients with restenosis at 3 years than Boston Scientific’s Eluvia DES, according to real-world data from the REALDES study....
Bloomington, Ind. — Cook Medical’s Zilver PTX drug-eluting stent (DES) has lower rates of in-stent occlusions among patients with restenosis at 3 years than Boston Scientific’s Eluvia DES, according to real-world data from the REALDES study....
Bloomington, Ind. — Cook...
03/27/2025
Vascular Disease Management
TAVR
Medtronic’s Evolut Trial Outcome Could Shake Up US TAVR Market, Says GlobalData
03/21/2025
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results...
03/21/2025
Vascular Disease Management
Embolotherapy
Instylla Completes Submission of Premarket Approval Application for Embrace™ Hydrogel Embolic System
03/11/2025
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025...
03/11/2025
Vascular Disease Management
Resistant Hypertension
Corcept Therapeutics Initiates MOMENTUM Trial to Determine Prevalence of Hypercortisolism in Patients with Resistant Hypertension
03/10/2025
“Resistant hypertension is a serious public health challenge. Patients whose hypertension remains in poor control despite receiving optimal care, including multiple medications, are at greater risk of cardiovascular morbidity and mortality,”...
“Resistant hypertension is a serious public health challenge. Patients whose hypertension remains in poor control despite receiving optimal care, including multiple medications, are at greater risk of cardiovascular morbidity and mortality,”...
“Resistant hypertension is a...
03/10/2025
Cath Lab Digest
Company expansion
Reflow Medical Expands Global Reach With New European Subsidiary
03/06/2025
Reflow Medical, Inc., a developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary in Landsberg am Lech, Germany.
Reflow Medical, Inc., a developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary in Landsberg am Lech, Germany.
Reflow Medical, Inc., a...
03/06/2025
Cath Lab Digest
SCAI
Survey Confirms Radiation and Orthopedic Health Hazards in Cardiac Catheterization Laboratories are ‘Unacceptable’
03/05/2025
A survey conducted by the Society for Cardiovascular Angiography and Interventions (SCAI) highlights ongoing radiation and orthopedic hazards faced by interventional cardiologists and cardiac catheterization laboratory (“cath lab” or CCL)...
A survey conducted by the Society for Cardiovascular Angiography and Interventions (SCAI) highlights ongoing radiation and orthopedic hazards faced by interventional cardiologists and cardiac catheterization laboratory (“cath lab” or CCL)...
A survey conducted by the...
03/05/2025
Cath Lab Digest
Shockwave Javelin Peripheral IVL Catheter, a novel intravascular lithotripsy (IVL) platform designed to modify calcium and cross extremely narrowed vessels in patients with peripheral artery disease (PAD).
IVL
Shockwave Medical Launches Novel Forward Intravascular Lithotripsy Platform in U.S. to Transform Treatment of Difficult-to-Cross Calcified Lesions
03/04/2025
Now available in the U.S., the Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter safely modifies and crosses occlusive or extremely narrowed calcific peripheral artery disease.
Now available in the U.S., the Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter safely modifies and crosses occlusive or extremely narrowed calcific peripheral artery disease.
Now available in the U.S., the...
03/04/2025
Cath Lab Digest
Acute Ischemic Stroke
FDA Approves Genentech’s TNKase® in Acute Ischemic Stroke in Adults
03/03/2025
Genentech announced that the U.S. FDA has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Genentech announced that the U.S. FDA has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Genentech announced that the...
03/03/2025
Vascular Disease Management
TEVAR
Zenith Alpha Thoracic 2 Now Available in US; First Case Performed
03/03/2025
Cook Medical’s Zenith Alpha® 2 Thoracic Endovascular Graft (ZTA2) is now commercially available throughout the United States.
Cook Medical’s Zenith Alpha® 2 Thoracic Endovascular Graft (ZTA2) is now commercially available throughout the United States.
Cook Medical’s Zenith Alpha® 2...
03/03/2025
Vascular Disease Management

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use